227 related articles for article (PubMed ID: 1646470)
1. Oleic acid as an inhibitor of gastric H+, K(+)-ATPase.
Murakami S; Muramatsu M; Otomo S
Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):337-50. PubMed ID: 1646470
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of gastric H+, K(+)-ATPase and acid secretion by ellagic acid.
Murakami S; Isobe Y; Kijima H; Nagai H; Muramatu M; Otomo S
Planta Med; 1991 Aug; 57(4):305-8. PubMed ID: 1663631
[TBL] [Abstract][Full Text] [Related]
3. Effect of salvianolic acid A, a depside from roots of Salvia miltiorrhiza, on gastric H+,K(+)-ATPase.
Murakami S; Kijima H; Isobe Y; Muramatsu M; Aihara H; Otomo S; Li LN; Ai CB
Planta Med; 1990 Aug; 56(4):360-3. PubMed ID: 2173008
[TBL] [Abstract][Full Text] [Related]
4. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
Reenstra WW; Pinkus LM; Bailey J; Smith WL; Droppleman D; Sancilio LF; Forte JG
J Pharmacol Exp Ther; 1992 May; 261(2):737-45. PubMed ID: 1315865
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gastric H+, K(+)-ATPase by chalcone derivatives, xanthoangelol and 4-hydroxyderricin, from Angelica keiskei Koidzumi.
Murakami S; Kijima H; Isobe Y; Muramatsu M; Aihara H; Otomo S; Baba K; Kozawa M
J Pharm Pharmacol; 1990 Oct; 42(10):723-6. PubMed ID: 1982146
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of tannic acid on gastric H+,K(+)-ATPase.
Murakami S; Muramatsu M; Otomo S
J Nat Prod; 1992 Apr; 55(4):513-6. PubMed ID: 1324983
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of gastric antisecretory effects of nolinium bromide.
Nandi J; Wright MV; Ray TK
Gastroenterology; 1983 Oct; 85(4):938-45. PubMed ID: 6309605
[TBL] [Abstract][Full Text] [Related]
8. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
Nagaya H; Satoh H; Kubo K; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):799-805. PubMed ID: 2537417
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
Nandi J; King RL; Kaplan DS; Levine RA
J Pharmacol Exp Ther; 1990 Mar; 252(3):1102-7. PubMed ID: 2156990
[TBL] [Abstract][Full Text] [Related]
11. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
Kinoshita M; Saito N; Noto T; Tamaki H
J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000.
Smolka AJ; Goldenring JR; Gupta S; Hammond CE
BMC Gastroenterol; 2004 Feb; 4():4. PubMed ID: 15028114
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
Wallmark B; Lorentzon P; Larsson H
Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a relationship between activity and the tetraprotomeric assembly of solubilized pig gastric H/K-ATPase.
Abe K; Kaya S; Taniguchi K; Hayashi Y; Imagawa T; Kikumoto M; Oiwa K; Sakaguchi K
J Biochem; 2005 Sep; 138(3):293-301. PubMed ID: 16169880
[TBL] [Abstract][Full Text] [Related]
15. SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase.
Keeling DJ; Laing SM; Senn-Bilfinger J
Biochem Pharmacol; 1988 Jun; 37(11):2231-6. PubMed ID: 2837231
[TBL] [Abstract][Full Text] [Related]
16. A newly synthesized pyridine derivative, (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine hydrochloride (AU-1421), as a reversible gastric proton pump inhibitor.
Hioki Y; Takada J; Hidaka Y; Takeshita H; Hosoi M; Yano M
Arch Int Pharmacodyn Ther; 1990; 305():32-44. PubMed ID: 2173509
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of gastric H+,K(+)-ATPase and acid secretion by cassigarol A, a polyphenol from Cassia garrettiana Craib.
Murakami S; Arai I; Muramatsu M; Otomo S; Baba K; Kido T; Kozawa M
Biochem Pharmacol; 1992 Jul; 44(1):33-7. PubMed ID: 1321629
[TBL] [Abstract][Full Text] [Related]
18. Effect of free fatty acids and detergents on H,K-ATPase. The steady-state ATP phosphorylation level and the orientation of the enzyme in membrane preparations.
Swarts HG; Van Uem TJ; Hoving S; Fransen JA; De Pont JJ
Biochim Biophys Acta; 1991 Dec; 1070(2):283-92. PubMed ID: 1662535
[TBL] [Abstract][Full Text] [Related]
19. Modulation of gastric H+,K+-transporting ATPase function by sodium.
Ray TK; Nandi J
FEBS Lett; 1985 Jun; 185(1):24-8. PubMed ID: 2987040
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the gastric (H+ + K+)-ATPase by fenoctimine.
Reenstra WW; Shortridge B; Forte JG
Biochem Pharmacol; 1985 Jul; 34(13):2331-4. PubMed ID: 2990481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
